Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Azithromycin for hospitalized children with asthmatic symptoms
2024-512605-29-01Phase 2Authorised
- Sponsor
- Capital Region of Denmark
- Start
- Jul 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of azithromycin in asthma (2 arms), sponsored by Capital Region of Denmark. Primary endpoint: Duration of asthma-like episode. Planned start Jul 2024; status: authorised.
02
Drugs
azithromycin
03
Conditions
asthma
Beyond the preview
Go deeper on 2024-512605-29-01.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2024-512605-29-01.